This was further corroborated by results from the analysis of the National Cancer Institute Genomic Data Commons (NCI GDC) TCGA PRAD cohort (n = 623), which showed that, while the GSE1 gene was significantly upregulated (1.36-fold, p = 1.88 × 10−7), the TACSTD2 gene expression was downregulated (0.98-fold, p = 2.58 × 10−1) in PCa, compared with the normal samples (Figure 1E,F). Here, TACSTD2 is linked to prostate adenocarcinoma.